Intellia Therapeutics, Inc.
← Back to NTLA Overview

Intellia Therapeutics, Inc. (NTLA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-3.96

Financial Fundamentals

NTLAQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-06-30-90.57
2014-12-31-2.23
2015-03-31-89.26
2015-06-30-32.50
2015-09-30-32.50
2015-12-31-18.42
2016-03-31-27.63
2016-06-30-14.83
2016-09-30-19.34
2016-12-31-10.57
2017-03-31-9.78
2017-06-30-8.89
2017-09-30-14.12
2017-12-31-7.88
2018-03-31-10.34
2018-06-30-13.15
2018-09-30-12.80
2018-12-31-7.94
2019-03-31-8.74
2019-06-30-7.33
2019-09-30-6.81
2019-12-31-6.43
2020-03-31-4.85
2020-06-30-8.61
2020-09-30-10.57
2020-12-31-19.71
2021-03-31-29.08
2021-06-30-40.08
2021-09-30-34.57
2021-12-31-27.08
2022-03-31-9.25
2022-06-30-9.75
2022-09-30-9.40
2022-12-31-6.25
2023-03-31-7.96
2023-06-30-7.27
2023-09-30-5.73
2023-12-31-5.22
2024-03-31-6.08
2024-06-30-3.70
2024-09-30-3.83
2024-12-31-2.30
2025-03-31-1.62
2025-06-30-2.39
2025-09-30-4.69
2025-12-31-2.71
2026-03-31-3.96

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.